Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: Preliminary results

A. Oliaro, P. L. Filosso, M. Bello, C. Casadio, A. Muni, B. Greco, G. Bertuccio, G. Bisi, G. Maggi

Research output: Contribution to journalArticlepeer-review

Abstract

The authors report their experience on the use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine carcinomas of the lung. The studies were performed both preoperatively, to obtain a correct staging of the tumor, or postoperatively, because of the suspicion of a recurrence or distant metastases. The main findings were: high sensitivity in localizing the tumor and its recurrences or metastases and high predictive value for responsiveness to "cold" octreotide therapy.

Original languageEnglish
Pages (from-to)653-656
Number of pages4
JournalJournal of Cardiovascular Surgery
Volume37
Issue number6
Publication statusPublished - Dec 1996
Externally publishedYes

Keywords

  • Carcinoma, neuroendocrine
  • Lung neoplasms
  • Lung radionuclide imaging
  • Neuroendocrine tumors
  • Octreotide diagnostic use

Fingerprint

Dive into the research topics of 'Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: Preliminary results'. Together they form a unique fingerprint.

Cite this